A detailed history of Mitchell Sinkler & Starr transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Mitchell Sinkler & Starr holds 2,800 shares of EW stock, worth $184,352. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,800
Holding current value
$184,352
% of portfolio
0.07%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$84.3 - $94.31 $236,040 - $264,068
2,800 New
2,800 $258,000
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $191,240 - $244,832
2,800 New
2,800 $208,000
Q1 2021

Apr 12, 2021

SELL
$78.68 - $90.67 $295,050 - $340,012
-3,750 Closed
0 $0
Q2 2020

Jul 20, 2020

BUY
$57.54 - $76.95 $215,775 - $288,562
3,750 New
3,750 $259,000
Q1 2020

Apr 07, 2020

SELL
$52.41 - $81.0 $55,030 - $85,050
-1,050 Closed
0 $0
Q4 2019

Jan 09, 2020

BUY
$71.7 - $82.09 $75,285 - $86,194
1,050 New
1,050 $245,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.7B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Mitchell Sinkler & Starr Portfolio

Follow Mitchell Sinkler & Starr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Sinkler & Starr, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Sinkler & Starr with notifications on news.